Knoll Capital Management, LLC - OCUPHIRE PHARMA INC ownership

OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 53 filers reported holding OCUPHIRE PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Knoll Capital Management, LLC ownership history of OCUPHIRE PHARMA INC
ValueSharesWeighting
Q2 2024$153,000
-23.9%
100,0000.0%0.10%
-17.6%
Q1 2024$201,000
-33.2%
100,0000.0%0.12%
-49.8%
Q4 2023$301,000
-10.1%
100,0000.0%0.25%
-28.4%
Q3 2023$335,000
-22.8%
100,0000.0%0.35%
-33.8%
Q2 2023$434,000
+15.7%
100,0000.0%0.53%
-9.0%
Q1 2023$375,000100,0000.58%
Other shareholders
OCUPHIRE PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Richmond Brothers, Inc. 191,304$292,6950.58%
Knoll Capital Management, LLC 100,000$153,0000.10%
Diametric Capital, LP 38,035$58,1930.03%
RICE HALL JAMES & ASSOCIATES, LLC 223,589$342,0910.02%
TRUST CO OF TOLEDO NA /OH/ 30,963$47,3730.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 163,741$250,5240.01%
Bedel Financial Consulting, Inc. 15,000$22,9500.00%
Stokes Family Office, LLC 12,120$18,5440.00%
CarsonAllaria Wealth Management, Ltd. 1,000$1,5300.00%
KESTRA PRIVATE WEALTH SERVICES, LLC 42,341$64,7820.00%
View complete list of OCUPHIRE PHARMA INC shareholders